A New Strategy for Tumor Treatment Targeting Immunometabolism Reprogramming in Traditional Chinese Medicine

Corresponding author: Xiao Yu-jie, 414737440@qq.com

DOI: 10.12201/bmr.202607.00005

•  

  Abstract: Tumor immune metabolic reprogramming plays a key role in the formation and development of the tumor microenvironment. Chinese medicine, with its advantages of holistic regulation and multi-target intervention, provides a unique theoretical basis and therapeutic strategy for regulating the immune metabolism of tumors. Traditional Chinese medicine effectively improves the immune microenvironment and enhances the anti-tumor immune response by regulating the metabolic pathways of tumor cells, promoting the metabolic functions of immune cells, and inhibiting the metabolic activity of immunosuppressive cells. The synergistic effects of multiple components in traditional Chinese medicine achieve dual regulation of metabolism and immunity, involving the regulation of key enzymes and immune signaling pathways, reflecting the overall advantages of traditional Chinese medicine in regulating complex metabolic networks.

  Key words: Traditional Chinese medicine; tumor; immune metabolic reprogramming

  Submit time: 1 July 2026

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• Tang Jian, Yu Ge. Targeting Tumor Microenvironment Metabolic Reprogramming: A New Strategy to Overcome Treatment Resistance in NSCLCZHI Chuanrui1,TANG Jian2,YU Ge2*. 2026. doi: 10.12201/bmr.202603.00010

  XUSHUCAI. Research progress on the anti-tumor effect of traditional Chinese medicine based on epigenetic mechanisms. 2026. doi: 10.12201/bmr.202603.00092

  wangminggang, luojuan, mozhengyuan, chenxinxin, wangxiufeng. The Role of Immune Cells and Traditional Chinese Medicine in Acute-on-Chronic Liver Failure. 2025. doi: 10.12201/bmr.202504.00030

  Dou Hongli. The Generative Logic, Value Implications, and Practical Pathways of Labor Education in Traditional Chinese Medicine. 2025. doi: 10.12201/bmr.202502.00040

  ZHENG Jian Yu. "Proof" and "Treatment" from the Perspective of Category Theory: Searching for the Underlying Structure of Traditional Chinese Medicine. 2026. doi: 10.12201/bmr.202603.00073

  Gao Lili. Research progress on targeting traditional Chinese medicine in the treatment of ischemic stroke based on the NLRP3 signaling pathway. 2025. doi: 10.12201/bmr.202509.00056

  Wang Huan, Ma Ying, Tian Jingnan, Lu Yi. Progress in the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Hypothyroidism from the Perspectives of Traditional Chinese and Western Medicine. 2025. doi: 10.12201/bmr.202505.00004

  Pengli Yang¹, Gaofeng Pang¹, Zheng Guo. Visual Analysis of Traditional Chinese Medicine in the Treatment of Mycoplasma Pneumoniae Pneumonia Based on CiteSpace. 2026. doi: 10.12201/bmr.202604.00142

  Li jie. Research Progress on the Treatment of Carotid Atherosclerotic Plaques with Traditional Chinese Medicine. 2025. doi: 10.12201/bmr.202512.00072

  莲承杰, ZHOU Kuichen, Xu Canli, BA Yinying, WANG Wenjuan, CHI Li, WANG Jiajia. Research Progress on the traditional Chinese medicine Treatment of Inflammatory Diseases Based on the Cuproptosis. 2026. doi: 10.12201/bmr.202601.00064

• ID	Submit time	Number	Download
  1	2026-05-16	10.12201/bmr.202607.00005V1	Download

• Public  Anonymous  To author only Submit Comments